申请人:Santhera Pharmaceuticals (Schweiz) GmbH
公开号:EP1702916A1
公开(公告)日:2006-09-20
The invention relates to compounds of formula (I)
wherein Z, R1-7, X and n have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
该发明涉及式(I)的化合物,其中Z、R1-7、X和n的含义如描述和权利要求中所述。所述化合物可用作DPP-IV抑制剂。该发明还涉及制备这种化合物以及其作为药物的生产和使用。